References
- Abo W, Chiba S, Yamanaka T, et al. (1979). Paralytic poliomyelitis in a child with agammaglobulinemia. Euro J Pediatr, 132, 11–6
- Alexander JP, Ehresmann K, Seward J, et al. (2009). Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. J Infect Dis, 199, 391–7
- Burns CC, Shaw J, Jorba J, et al. (2013). Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol, 87, 4907–22
- Center for Disease Control and Prevention (CDC). (2003). Progress toward poliomyelitis eradication—Ethiopia, Somalia, and Sudan, January 2001–October 2002. JAMA, 289, 1095–7
- Center for Disease Control and Prevention (CDC). (2006). Update on vaccine-derived polioviruses. MMWR, 55, 1093–7
- Center for Disease Control and Prevention (CDC). (2007). Update on vaccine-derived polioviruses—worldwide, January 2006–August 2007. MMWR, 56, 996–1001
- Center for Disease Control and Prevention (CDC). (2011). Update on vaccine-derived polioviruses—worldwide, July 2009–March 2011. MMWR, 60, 846–50
- Center for Disease Control and Prevention (CDC). (2012a). Update on vaccine-derived polioviruses—worldwide, April 2011–June 2012. MMWR, 61, 741–6
- Center for Disease Control and Prevention (CDC). (2012b). Progress toward interruption of wild poliovirus transmission—worldwide, January 2011–March 2012. MMWR, 61, 353–7
- Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, et al. (2009). Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. J Investig Allergol Clin Immunol, 19, 139–45
- Davis LE, Bodian D, Price D, et al. (1977). Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. New Engl J Med, 297, 241–5
- Devries AS, Harper J, Murray A, et al. (2011). Vaccine-derived poliomyelitis 12 years after infection in Minnesota. N Engl J Med, 364, 2316–23
- Dowdle WR, De Gourville E, Kew OM, et al. (2003). Polio eradication: The OPV paradox. Rev Med Virol, 13, 277–91
- Guillot S, Caro V, Cuervo N, et al. (2000). Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol, 74, 8434–43
- Henry JL, Jaikaran ES, Davies JR, et al. (1966). A study of poliovaccination in infancy: Excretion following challenge with live virus by children given killed or living poliovaccine. J Hyg, 64, 105–20
- Kew OM, Sutter RW, De Gourville EM, et al. (2005). Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann Rev Microbiol, 59, 587–635
- Khetsuriani N, Prevots DR, Quick L, et al. (2003). Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis, 188, 1845–52
- Mamishi S, Shahmahmoudi S, Tabatabaie H, et al. (2008). Novel BTK mutation presenting with vaccine-associated paralytic poliomyelitis. Eur J Pediatr, 167, 1335–8
- Murdin AD, Barreto L, Plotkin S. (1996). Inactivated poliovirus vaccine: Past and present experience. Vaccine, 14, 735–46
- Parvaneh N, Shahmahmoudi S, Tabatabai H, et al. (2007). Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency. J Clin Virol: Pan Amer Soc Clin Virol, 39, 145–8
- Rosen FS, Cooper MD, Wedgwood RJ. (1995). The primary immunodeficiencies. New Engl J Med, 333, 431–40
- Sasaki A, Haraguchi Y, Yoshida H. (2012). Estimating the risk of re-emergence after stopping polio vaccination. Front Microbiol, 3, 1–13
- Shahmahmoodi S, Mamishi S, Aghamohammadi A, et al. (2010). Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995–2008. Emerg Infect Dis, 16, 1133–6
- Wright PF, Hatch MH, Kasselberg AG, et al. (1977). Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. J Pediatr, 91, 408–12
- World Health Organization (1997). manual for the virological investigation of polio. WHO/EPI/GEN/97.01